Use of Ave5026 for minimizing the incidence of bleedings during an antithrombotic treatment
Details for Australian Patent Application No. 2008255191 (hide)
International Classifications
Event Publications
8 January 2009 Complete Application Filed
24 June 2010 Application Open to Public Inspection
Published as AU-A-2008255191
24 June 2010 Corrigenda
Complete Applications Filed - Name Index Under the name Sanofi-Aventis, Application No. 2008255191, under INID (54) correct the title to read Use of Ave5026 for minimizing the incidence of bleedings during an antithrombotic treatment
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008255192-Detection of a biomarker of aberrant cells of neuroectodermal origin in a body fluid
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser